Arvinas (ARVN) Cash from Operations (2017 - 2026)

Arvinas' (ARVN) quarterly Cash from Operations came in at 69200000.0 in Q1 2026, up 22.16% year-on-year from 56647145.49 in Q1 2025, and down 127.63% quarter-over-quarter from 30400000.0 in Q4 2025.

Arvinas (ARVN) Cash from Operations (2017 - 2026) Analysis & Trends

Arvinas' Cash from Operations history runs 10 years deep, the most recent figure standing at 69200000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 22.16% year-over-year to 69200000.0 in Q1 2026; TTM through Mar 2026 was 254100000.0, a 1.36% decrease from a year earlier, with the FY2025 full-year figure at 273800000.0, down 5.59% from the prior year.
  • Cash from Operations fell to 69200000.0 in Q1 2026 per ARVN's latest filing, from 30400000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 50300000.0 in Q2 2024 and bottomed at 128000000.0 in Q3 2024.
  • The 5-year median for Cash from Operations is 83100000.0 (2023), against an average of 71976470.59.
  • Across the five-year window, Cash from Operations jumped 156.71% in 2024 and plunged 289.66% in 2025, its largest moves.
  • Year by year, Cash from Operations stood at 71200000.0 in 2022, then decreased by 16.71% to 83100000.0 in 2023, then decreased by 1.2% to 84100000.0 in 2024, then surged by 63.85% to 30400000.0 in 2025, then sank by 127.63% to 69200000.0 in 2026.
  • Per Business Quant, the three latest ARVN Cash from Operations figures stand at 69200000.0 (Q1 2026), 30400000.0 (Q4 2025), and 59100000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 Arvinas 519.68 Mn -95.22 Mn - -69.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -69.20 Mn
Mar 31, 2026 -69.20 Mn
Dec 31, 2025 -30.40 Mn
Dec 31, 2025 -30.40 Mn
Sep 30, 2025 -59.10 Mn
Sep 30, 2025 -59.10 Mn
Jun 30, 2025 -95.40 Mn
Jun 30, 2025 -95.40 Mn
Mar 31, 2025 -88.90 Mn
Mar 31, 2025 -88.90 Mn
Dec 31, 2024 -84.10 Mn
Dec 31, 2024 -84.10 Mn
Sep 30, 2024 -128.00 Mn
Sep 30, 2024 -128.00 Mn
Jun 30, 2024 50.30 Mn
Jun 30, 2024 50.30 Mn
Mar 31, 2024 -97.50 Mn
Mar 31, 2024 -97.50 Mn
Dec 31, 2023 -83.10 Mn
Dec 31, 2023 -83.10 Mn